下颌下腺与吞咽结构保护对口咽癌IMRT后PEG依赖的影响
结果显示对侧SMG(cSMG)剂量是PEG依赖时间的独立预测因素,cSMG剂量低于中位数42 Gy的患者PEG拔除时间显著更短(中位1.9 vs 3.5个月,p<0.0001),6个月时PEG依赖率3% vs 31%(p=0.002)。
要点
- cSMG剂量是PEG依赖时间的独立预测因素(HR 0.97/Gy,95%CI 0.95-0.98,p<0.0001)
- cSMG剂量<42 Gy者中位PEG拔除时间1.9个月,>42 Gy者3.5个月(p<0.0001)
- 6个月时cSMG<42 Gy组PEG依赖率3%,>42 Gy组31%(p=0.002)
核心结论
- 保护对侧下颌下腺的放疗可显著缩短口咽癌患者放疗后PEG管拔除时间,提示亚急性吞咽困难有临床意义的减轻。
研究设计与样本
- 勾画唾液腺及吞咽相关危及器官(包括咽缩肌),主要终点为放疗结束至脱离PEG依赖的时间。
- 采用Cox比例风险回归和逻辑回归评估正常组织剂量对吞咽相关终点的影响。
主要发现
- 全部患者为III/IV期,97%接受同步全身治疗。
- 单因素分析中cSMG剂量是最强PEG依赖时间预测因子(HR 0.97/Gy,95%CI 0.95-0.98,p<0.0001),多因素分析p=0.052。
- 上/中咽缩肌及喉部剂量在单因素分析中亦显著。
关键数值与推荐
- cSMG剂量低于中位数42 Gy者(n=34)中位PEG拔除时间1.9个月,高于42 Gy者3.5个月(p<0.0001)。
- 6个月时cSMG<42 Gy组PEG依赖率3%,cSMG>42 Gy组31%(p=0.002)。
临床怎么用
- 在口咽癌IMRT计划中应关注对侧下颌下腺剂量,将其作为保护吞咽功能、减少PEG依赖的剂量学目标。
- 将cSMG平均剂量控制在42 Gy以下可能缩短PEG管依赖时间。
局限性
- 多因素分析中cSMG剂量与PEG依赖时间的关联仅达临界显著性(p=0.052)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation therapy-related dysphagia is worsened by xerostomia. The submandibular glands (SMG) produce saliva rich in lubricating mucins, and sparing the SMG has been shown to reduce xerostomia. The goal of this study was to determine whether SMG sparing IMRT is associated with reduced post-treatment PEG dependence in locally advanced oropharynx cancer patients. METHODS: Patients treated with definitive radiation therapy for oropharynx cancer were included in this retrospective study. Those with disease recurrence were excluded. Salivary glands and swallowing-related organs at risk, including pharyngeal constrictors, were contoured. Primary endpoint was time from end of radiation treatment to freedom from gastrostomy (PEG) tube dependence. Cox proportional hazards regression and logistic regression were used to assess influence of normal tissue doses on swallowing related endpoints. RESULTS: Sixty-nine patients were included. All had stage III/IV disease and 97% received concurrent systemic therapy. Fifty-seven percent had contralateral SMG (cSMG) mean dose <50 Gy, a level shown to predict for xerostomia. Eighty four percent of patients had a PEG tube placed electively. On univariate analysis, the strongest predictor of time to freedom from PEG tube dependence was cSMG dose (HR 0.97 per Gy (95% CI 0.95-0.98), p < 0.0001). This relationship persisted on multivariate analysis (p = 0.052). The dose to superior and middle pharyngeal constrictor muscles, and larynx were also significant on univariate analysis. Patients with cSMG dose less than median (42 Gy, n = 34) had a significantly shorter time to freedom from PEG dependence: median 1.9 vs. 3.5 months, p < 0.0001. At 6 months, 3% of patients with cSMG dose < 42 Gy were PEG dependent compared to 31% with cSMG dose > 42 Gy (p = 0.002). CONCLUSIONS: Patients treated with cSMG sparing radiotherapy had significantly shorter time to PEG tube removal after treatment, suggesting a clinically meaningful reduction in subacute dysphagia compared to non-cSMG sparing treatment.
引用
- Gensheimer MF, Nyflot M, Laramore GE, et al. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique. Radiat Oncol. 2016. PMID: 27846899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。